US Surgical has new products line-up on show
This article was originally published in Clinica
Chairman Leon Hirsch says US Surgical is no longer losing market share to Ethicon, but is holding its place in both the suture and MIS market. The company displayed a much wider range of products at this year's American College of Surgeons annual clinical congress than in previous years including a significant number of new and improved items. Work in the pipeline includes such diverse products as xenograft organs and minimally invasive heart surgery equipment.
You may also be interested in...
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
Hikma and Sesen Bio have struck a deal that will see Hikma distribute the Vicineum brand in the MENA region.
By establishing a dedicated consumer healthcare subsidiary, Norgine is hoping it can grow its $200m-plus Movicol laxative brand and take advantage of M&A opportunities in the OTC market.